Press Releases
Qualified and institutional investors as well as advisors and analysts are invited to attend its real-time, interactive presentation at the Emerging Growth Conference June 12.
HOUSTON--(BUSINESS WIRE)-- Diakonos Oncology Corporation (“Diakonos”), a clinical stage immuno-oncology company, announced today that it will present at the Emerging Growth Conference on Wednesday, June 12. The company’s presentation, including Q&A, will run from 1:10 pm -1:40 pm Eastern... (continue reading...)
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeTouchstone Exploration... (continue reading...)FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeFireAngel Safety Technology Group... (continue reading...)FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereemusicMagpie Plc(c) Name of... (continue reading...)FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNewRiver REIT Plc(c) Name... (continue reading...)More Press Releases
View Older Stories-
Shelly Group announces the integration of Wave Plug US within the Samsung SmartThings ecosystem
-
Microsoft to help rural hospitals defend against rising cybersecurity attacks
-
PlasCred Circular Innovations Inc. Announces Q1 2024 Results
-
Flash News: OKX Wallet Now Supports Moonland Meta
-
51Talk Online Education Group to Report First Quarter 2024 Financial Results on Wednesday, June 12, 2024
-
SCI Ventures Launches Venture Philanthropy Fund to Accelerate Restorative Treatments for Spinal Cord Injury and a Cure for Paralysis
-
KMS Lighthouse completed a roadshow with its partner Microsoft in 4 cities around the world: Orlando, London, Tel Aviv and Dallas
-
Aptar Digital Health Partners with SHL Medical to Optimize Patient Experience with Self-Injectable Therapies
-
Tyra Banks, Supermodel Headlined TWEF’s Sold-Out International Women’s Leadership Summit, Hosted By Founder Deavra Daughtry for Youth Scholarships
-
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
-
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery Conference in Berlin
-
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
-
GKN Automotive reduces direct CO2e emissions by 10.5% in 2023
-
The Ultimate Guide to Renewable Energy Sources for Sustainable Living
-
Why This Business Building Platform is Creating So Much Noise Among Gen Zs
-
Genesis Releases Wildfire Defence Solutions AI Tool
-
2024 Begins Drilling at Agate
-
F3 Advances F4 Spin Out
-
SHARE BUYBACK TRANSACTIONS
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc. AMENDMENT
-
S&P Global Ratings Maalot Reaffirms Elbit Systems' Long Term Rating of "ilAA" (Local Scale), With a Stable Outlook and Short Term Rating of "ilA-1+" (Local Scale)
-
CLA Global Welcomes New CEO
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc. AMENDMENT
-
Prepayments, Realkredit Danmark A/S
-
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in Singapore
-
Danske Bank share buy-back programme: Transactions in week 23
-
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
-
Nippon Express U.S.A. Introduces First Electric Truck
-
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
-
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
-
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moderate Alopecia Areata
-
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
-
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
-
GBP K.K. to Showcase Cutting-Edge Energy Solutions at Intersolar Europe 2024
-
DFDS DIVESTS OSLO CRUISE FERRY ROUTE TO ENHANCE TRANSPORT FOCUS
-
Transactions in connection with share buyback programme
-
Understanding Travel Hacking: What It Is and How to Apply It
-
Fast Poker, Free Bets and Free Spins at Everygame Poker
-
DFDS to sell Oslo-Frederikshavn-Copenhagen route to Gotlandsbolaget
-
TransNusa's International Route Growth Strategy a Success
-
Flash News: OKX Announces Launch of Fixed Simple Earn and VIP Loan
-
Play With $1000 More at Juicy Stakes Casino
-
Alm. Brand A/S – Weekly report on share buybacks
-
Global Startup Ecosystem Report 2024 Showcases Surging Investment in Generative AI
-
XRP Healthcare Welcomes 10 Billion Dollar M&A Specialist Whitney Lynn to Head Africa Expansion
-
Ariceum Therapeutics to Present Outstanding New Preclinical Data at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2024
-
Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics